{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:30:34Z","timestamp":1789140634705,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.clinbiochem.2023.110616","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T12:52:57Z","timestamp":1690289577000},"page":"110616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Circulating interleukin-39 as a potential biomarker for rheumatoid arthritis diagnosis"],"prefix":"10.1016","volume":"119","author":[{"given":"Lina","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sicen","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiudi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingcai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clinbiochem.2023.110616_b0005","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110616_b0010","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.3390\/ijms23052871","article-title":"Inflammation and bone metabolism in rheumatoid arthritis: molecular mechanisms of joint destruction and pharmacological treatments","volume":"23","author":"Maeda","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110616_b0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-3083.2009.02361.x","article-title":"IL-23 in the pathogenesis of rheumatoid arthritis","volume":"71","author":"Paradowska-Gorycka","year":"2010","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2023.110616_b0020","doi-asserted-by":"crossref","first-page":"A288","DOI":"10.1016\/j.autrev.2009.11.019","article-title":"The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis","volume":"9","author":"Tob\u00f3n","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110616_b0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/s10165-007-0015-y","article-title":"Interleukin-17 gene expression in patients with rheumatoid arthritis","volume":"18","author":"Kohno","year":"2008","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.clinbiochem.2023.110616_b0030","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.12659\/MSM.896355","article-title":"Interleukin-6 (IL-6) receptor antagonist protects against rheumatoid arthritis","volume":"22","author":"Li","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.clinbiochem.2023.110616_b0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cyto.2018.07.027","article-title":"Elevated levels of IL-37 correlate with T cell activation status in rheumatoid arthritis patients","volume":"113","author":"Ragab","year":"2019","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.clinbiochem.2023.110616_b0040","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Vignali","year":"2012","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110616_b0045","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3934\/mbe.2015.12.1203","article-title":"The role of the cytokines IL-27 and IL-35 in cancer","volume":"12","author":"Friedman","year":"2015","journal-title":"Math. Biosci. Eng."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110616_b0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1535370218824547","article-title":"IL-12 and IL-23\/Th17 axis in systemic lupus erythematosus","volume":"244","author":"Larosa","year":"2019","journal-title":"Exp. Biol. Med."},{"issue":"6","key":"10.1016\/j.clinbiochem.2023.110616_b0055","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/eji.201546095","article-title":"A novel IL-23p19\/Ebi3 (IL-39) cytokine mediates inflammation in Lupus-like mice","volume":"46","author":"Wang","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2023.110616_b0060","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/molecules21111565","article-title":"Circulating IL-27 is elevated in rheumatoid arthritis patients","volume":"21","author":"Lai","year":"2016","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110616_b0065","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jim-2018-000814","article-title":"Elevated serum IL-35 levels in rheumatoid arthritis are associated with disease activity","volume":"67","author":"Li","year":"2019","journal-title":"J. Invest. Med."},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110616_b0070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrrheum.2012.170","article-title":"Possible roles of IL-12-family cytokines in rheumatoid arthritis","volume":"9","author":"Pope","year":"2013","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110616_b0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/ard.2007.082081","article-title":"Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis","volume":"68","author":"Brentano","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110616_b0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12865-021-00431-x","article-title":"Serum IL-35 is decreased in overweight patients with rheumatoid arthritis: its correlation with Th1\/Th2\/Th17-related cytokines","volume":"22","author":"Li","year":"2021","journal-title":"BMC Immunol."},{"key":"10.1016\/j.clinbiochem.2023.110616_b0085","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1038\/emm.2013.89","article-title":"In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis","volume":"45","author":"Moon","year":"2013","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110616_b0090","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/cei.12840","article-title":"Interleukin (IL)-39 [IL-23p19\/Epstein-Barr virus-induced 3 (Ebi3)] induces differentiation\/expansion of neutrophils in lupus-prone mice","volume":"186","author":"Wang","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110616_b0095","first-page":"1660","article-title":"AntiIL39 (IL23p19\/Ebi3) polyclonal antibodies ameliorate autoimmune symptoms in lupuslike mice","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.clinbiochem.2023.110616_b0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5603\/FHC.a2021.0019","article-title":"IL-39 increases ROS production and promotes the phosphorylation of p38 MAPK in the apoptotic cardiomyocytes","volume":"59","author":"Xiong","year":"2021","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.clinbiochem.2023.110616_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102430","article-title":"Elevated serum interleukin-39 levels in patients with neuromyelitis optica spectrum disorders correlated with disease severity","volume":"46","author":"Yang","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110616_b0110","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/08923973.2020.1869778","article-title":"Interleukin-39 exacerbates concanavalin A-induced liver injury","volume":"43","author":"Li","year":"2021","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2023.110616_b0115","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an american college of rheumatology\/european league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.clinbiochem.2023.110616_b0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/08959374960100010901","article-title":"Autoimmune mechanisms involved in the pathogenesis of rheumatoid arthritis","volume":"10","author":"Williams","year":"1996","journal-title":"Adv. Dent. Res."},{"issue":"2","key":"10.1016\/j.clinbiochem.2023.110616_b0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1615\/CritRevImmunol.2016018175","article-title":"Natural IgM and the development of B cell-mediated autoimmune diseases","volume":"36","author":"Nguyen","year":"2016","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.clinbiochem.2023.110616_b0130","first-page":"159","article-title":"Mechanisms of death and tissue injury in malaria. IX. Adrenal insufficiency","volume":"64","author":"Omran","year":"2022","journal-title":"J Fac Med Baghdad"},{"issue":"4","key":"10.1016\/j.clinbiochem.2023.110616_b0135","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.24996\/ijs.2023.64.4.8","article-title":"A novel link of serum IL-39 levels in patients with rheumatoid arthritis","volume":"64","author":"Al Ghuraibawi","year":"2023","journal-title":"Iraqi J. Sci."},{"issue":"9","key":"10.1016\/j.clinbiochem.2023.110616_b0140","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1002\/art.38736","article-title":"Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritis","volume":"66","author":"Glaesener","year":"2014","journal-title":"Arthritis Rheumatol."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023001443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912023001443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:59:25Z","timestamp":1757865565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912023001443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":28,"alternative-id":["S0009912023001443"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110616","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating interleukin-39 as a potential biomarker for rheumatoid arthritis diagnosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110616"}}